prostate cancer Archives - Healthcare Communications Network

HMP CommunicationsAUA, ASTRO, and SUO Release Consensus Guideline on Advanced Prostate Cancer

Published on the AUA website and developed by a panel of experts from these three groups as well as representation from the American Society of Clinical Oncology (ASCO) and a patient advocate, 38 recommendations are listed across the care continuum of advanced disease.

WebMDFDA Approves Rubraca, First PARP Inhibitor for Prostate Cancer

Already approved to treat ovarian cancer, Rubraca (rucaparib) has been granted accelerated approval as the first PARP inhibitor to treat certain patients with prostate cancer, offering a completely new approach for physicians.